IT·Science
Technology
[Big Tech Enters New Drug Development] 2.9 Trillion vs. 16 Billion… Success of South Korean AI-Driven New Drugs Depends on “Stamina,” Not Algorithms
Isomorphic Labs, a spin-off from Google DeepMind, raised approximately 2.9 trillion won in a single funding round last May. During the same period, the Series B funding round for a leading South Korea…
Technology
Hanol Bio’s ‘Imeropruvate’ Fails to Meet Primary Endpoint in Phase 2b Lupus Clinical Trial… Development Halted
ImmunoVant, a partner company of HANALL BIOPHARMA CO.,LTD(009420), failed to meet the primary endpoint in the proof-of-concept (PoC) clinical trial for “Imeropruvate” (IMVT-1402), a treatment for auto…
Technology
[Big Tech Enters New Drug Development: Part 1] Google Becomes First Big Tech Company to Conduct 'In-House Clinical Trials'… Will This Shake Up the New Drug Development Landscape?
Isomorphic Labs, a spin-off from Google DeepMind, is reportedly on the verge of entering the first human clinical trial for a new cancer drug designed using artificial intelligence (AI). If successful…
Technology
HLB INC., Which Failed Three Times with Liver Cancer, Gains FDA Approval for Bile Duct Cancer… ‘Ripictu’ Approved in the U.S.
"Lirapugratinib" (RLY-4008), a bile duct cancer treatment for which HLB INC.(028300)has secured global commercialization rights, has received approval from the U.S. Food and Drug Administration (FDA).…
Telecommunications & Broadcasting
“IPTV: Only 3-Year Contracts?”… The “Shackles” of Online Sign-Ups Are Disappearing
Going forward, consumers will be able to freely choose their contract term when signing up for IPTV online. This is because KTCorporation had limited online sign-ups to a 3-year contract only, while S…
Internet
Listing a Subsidiary: Who Does It Benefit?… Kakao’s Take on ‘Shareholder Value’
Is listing a subsidiary on the stock market to recoup investment funds from financial investors (FIs) also beneficial to the parent company’s general shareholders? As Kakao puts the brakes on Kakao Mo…
Technology
ABL Bio Inc.’s ‘ABL001’ U.S. Approval Application by Year-End Put on Hold?…FDA Recommends Additional Clinical Trials
The prospect of submitting a Biologics License Application (BLA) to the U.S. within the year for “Tobesimig” (ABL001), a bispecific antibody for bile duct cancer developed and licensed by ABL Bio Inc.…
Internet
“Walking robots are a thing of the past”… Humanoids Now Compete on ‘How Much Work They Can Do’
The phase where people cheered at the sight of robots walking like humans is rapidly fading. Attention is now shifting to what those robots can actually do in the field and how long they can work reli…
Internet
AI Determines Whether Documents Are ‘Confidential’… Hancom WITH and Connectorie Join Forces
Hancom WITH(054920)is embarking on the development of technology that uses artificial intelligence (AI) to analyze the content and context of documents and automatically classify them by security leve…
Technology
Japanese Stroke AI Expert: "Korean Medical AI Technologies, Such as JLK, Inc., Play a Major Role in Japan"
"I was impressed by South Korea's AI medical technology. If accurate, clear, and objective indicators are automatically provided, it could significantly reduce the burden on medical staff in the treat…